- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Diagnostic display expands screen space
With a 30-inch screen, the new 4-megapixel diagnostic display from Planar provides a better fit for multiple images. The Dome E4c exhibited at the RSNA meeting can show 15 full-size 512 x 512 matrix images, promoting increased productivity, particularly when viewing large data sets and studies with multiple series.
With a 30-inch screen, the new 4-megapixel diagnostic display from Planar provides a better fit for multiple images. The Dome E4c exhibited at the RSNA meeting can show 15 full-size 512 x 512 matrix images, promoting increased productivity, particularly when viewing large data sets and studies with multiple series.
The 16:9 format of the bezel-less Dome E4c simplifies comparison studies by eliminating image split caused by the bezel of a dual-headed monitor. The 4-megapixel resolution displays more than 90% of a computed radiography image without scaling, according to the company. The combination of the wide screen and 4-megapixel resolution allows the E4c to display a 25% larger landscape image than a 3-megapixel monitor.
The E4c is suitable for viewing 2D color images as well as image fusion and 3D reconstructions with volumetric and multiplanar images. The monitor shows 16.7 million colors as well as 256 shades from a palette of 1786 unique shades of gray. It also has 330 cd/meter² typical brightness and 700:1 contrast ratio.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
